Medical Marijuana Inc.'s HempMeds Featured in Groundbreaking Cable TV Documentary on Cannabidiol (CBD)
August 19, 2014 --
SAN DIEGO, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC Pink:MJNA) is extremely proud to announce that its subsidiary company, HempMeds™, is being featured in a groundbreaking documentary on industrial hemp cannabidiol (CBD) by AWE TV.
"As the cannabis industry goes 'mainstream,' many are only viewing 'marijuana' as a source of cannabidiol or 'CBD,'" comments Andrew Hard, Director of Public Relations for HempMeds™. "AWE TV's goal with the 'Journey to Health' documentary is to share with their audience that there is another side of the cannabis story: industrial hemp-derived CBD – which our company has pioneered for years. AWE TV's 'Journey to Health' documentary footage sets the record straight that 'CBD,' a natural constituent of the cannabis plant that is in global demand, is available online in all 50 states and more than 40 countries."
There are an estimated 16.2 million viewers who can access AWE TV through its hundreds of cable television carriers. AWE TV broadcasts also stream live through ROKU™, Boxee™, Samsung™ connected TVs and Panasonic™ 2011+ connected TVs. AWE TV also provides 3D content on VUDU.
Hard continues, "The mainstream news media has portrayed a national shortage of CBD. HempMeds™ is proud to be the world's leader in CBD-rich hemp oil product distribution. We are grateful that AWE TV wanted to explain to their viewers that there is no shortage of CBD-rich hemp oil and accessing it online is simple."
To date, there are twenty three medical marijuana states and the District of Columbia. Mainstream news reports of the perceived shortage of CBD that has spurred national issues such as "medical marijuana refugees" flocking to Colorado. The national increase in awareness of CBD has also prompted eleven non-legalized medical marijuana states to adopt "CBD-only" laws.
Hard concludes, "At HempMeds™, we believe 'knowledge is power'. With thirty-four of fifty states and the District of Columbia voting to support cannabis use for their residents, one can clearly see that the public is rapidly becoming more aware of the potential uses for this ancient - yet once recently historically demonized - plant. Our entire 'seed to shelf' operational supply chain ranges from the world's leading cannabis scientists, European generational farmers, importers and distributors. We are very proud that the public will soon see the industrial hemp plant in a whole new light. It has taken years of effort to ensure that there is ample global supply and, more importantly, 'access for all' to CBD-rich hemp oil. As one will see in the AWE TV documentary 'Journey to Health', there is no need to move to a legalized cannabis state if one turns to industrial hemp-based CBD as the source."
HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company's exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell, and distribute hemp-based products and is involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT: For further information, please contact:
Investor relations contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Media relations contact:
Director of Public Relations